Edward A. Copelan

Edward A. Copelan

Hematology | Oncology

1021 Morehead Medical Drive
Building 2, Suite 60201
Charlotte, NC 28204

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 112 publications

HMA/VEN: A New Pretransplant Paradigm for SOME People with AML.

HMA/VEN: A New Pretransplant Paradigm for SOME People with AML.

Journal: Transplantation and cellular therapy

Published: May 20, 2026

Hematopoietic cell transplantation in first relapse of (CBF- and other) AML.

Hematopoietic cell transplantation in first relapse of (CBF- and other) AML.

Journal: Bone marrow transplantation

Published: September 15, 2025

Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.

Pretransplant Conditioning for Hematopoietic Cell Transplants: The Past Is Prologue.

Journal: Transplantation and cellular therapy

Published: May 05, 2025

Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the PROS.

Hematopoietic cell transplantation soon after first relapse in acute myeloid leukemia - the PROS.

Journal: Haematologica

Published: January 01, 2025

Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.

Evaluation of the Impact of Monitoring for Tumor Lysis During Venetoclax Ramp-Up in Chronic Lymphocytic Leukemia in Routine Clinical Practice.

Journal: JCO oncology practice

Published: November 18, 2024

Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders.

Editorial: Transplantation and cellular therapy in lymphomas and plasma cell disorders.

Journal: Frontiers in oncology

Published: November 13, 2024

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Biologically Randomized Comparison of Haploidentical Versus Human Leukocyte Antigen-Matched Related Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: July 15, 2024

Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.

Real-World Analysis of Barriers to Timely Administration of Chimeric Antigen Receptor T Cell (CAR T) Therapy in Diffuse Large B-cell Lymphoma.

Journal: Transplantation and cellular therapy

Published: April 29, 2024

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Venous Thromboembolism Incidence and Risk Factors in Patients Undergoing Hematopoietic Stem Cell Transplantation.

Journal: Transplantation and cellular therapy

Published: March 08, 2024

TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas.

TP53 upregulation via aurora kinase inhibition overcomes primary failure to venetoclax in BCL2-rearranged lymphomas.

Journal: iScience

Published: January 31, 2024

Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes.

Evaluation of pentamidine tolerability and efficacy between CYP2C19 phenotypes.

Journal: Pharmacogenomics

Published: October 17, 2023

Transplantation and cellular therapy in acute leukemia.

Transplantation and cellular therapy in acute leukemia.

Journal: Best practice & research. Clinical haematology

Published: August 23, 2023

Showing 1-12 of 112

Last Updated: 09/26/2026